NPM1 and acute myeloid leukemia: Of note, Falini et al. previously documented, in a large series of 318 NPM1-mutated AML patients, that multilineage dysplasia, detected in approximately 23% of cases, had no significant impact on gene expression profile or pathologic, immunophenotypic, clinical, and prognostic features of NPM1-mutated AML.